Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'

Published 19/03/2024, 13:55
Updated 19/03/2024, 15:10
© Reuters.  Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. "We got to wait," he added.

Last week, Marvell Technology unveiled a significant development in semiconductor technology through an expanded partnership with Taiwan Semiconductor Manufacturing Co (NYSE: TSM), launching the first-ever 2nm silicon intellectual property (IP) technology platform.

Cramer recommended buying Datadog, Inc. (NASDAQ: DDOG), saying that it is a "dynamite" company. "It is expensive, but they really know what they’re doing," he noted.

On Feb. 13, Datadog posted upbeat sales for its fourth quarter, but issued FY24 EPS guidance below estimates. The company clocked fourth-quarter FY23 revenue growth of 26% year-on-year to $589.649 million, beating the consensus of $568.695 million.

When asked about Centrus Energy Corp. (NYSE: LEU), he said, "Very speculative situation. I want you to buy the GE spinoff that’s coming, it’s Vernova. That has got nuke, and I love the balance sheet, and I love what the company’s doing, and you want to be a little diversified."

On Feb. 8, Centrus Energy reported better-than-expected fourth-quarter financial results.

Don’t forget to check out our premarket coverage here

Altimmune, Inc. (NASDAQ: ALT) is an "absolute, without a doubt, high-risk stock, when you could have Eli Lilly (NYSE: LLY)," Cramer said.

Last month, Kerrisdale Capital announced a short position in the stock, claiming the company had little chance of competing against others in the GLP-1 space and calling it an “obvious dead end.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

When asked about Lantheus Holdings, Inc. (NASDAQ: LNTH), he said, "I’ve been preferring RadNet (NASDAQ: RDNT), because I think they’ve got a better business model."

On March 4, Lantheus announced the FDA approval of DEFINITY for pediatric patients.

"They were doing great, and then they did this convertible bond, and it just wrecked the stock," the "Mad Money" host said about SoFi Technologies, Inc. (NASDAQ: SOFI). "The stock has just been in the dog house ever since, and I don’t like it when I tell people to buy a stock and it’s staying in the dog house. We got to find out what the heck is going on there."

On March 5, SoFi Technologies announced a proposed $750 million convertible senior notes offering due 2029.

Cramer said On Holding AG (NYSE: ONON) had a "controversial" quarter. "I am on the fence on On," he added.

Price Action

  • Shares of Marvell Technology gained 0.5% to close at $67.20 on Monday.
  • Datadog shares gained 0.4% to close at $120.87 on Monday.
  • Centrus Energy shares gained 1.4% to settle at $38.77.
  • Altimmune shares dipped 7.9% to settle at $9.08 on Monday.
  • Lantheus shares fell 2.8% to close at $56.52 on Monday.
  • Shares of SoFi rose 0.7% to settle at $7.08.
  • On Holding shares fell 0.4% to close at $33.10 on Monday.

Image: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.